HJC0152 increased the expression of E‐cadherin but decreased the expression of N‐cadherin and vimentin (Figure 5G and H), suggesting that HJC0152 inhibits acquisition of mesenchymal characteristics in NSCLC cells. Here, CDH1 is linked to non-small cell lung carcinoma.